• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Galen Institute

  • Home
  • About Us
    • Mission and History
    • Grace-Marie Turner bio
    • Who was Galen?
  • Activities
    • Core Activities
    • Commentary and Oped Tutorial
    • Our Book
    • Galen Guides
  • Contact Us
  • Major Papers
  • Broadcast Interviews
  • Health Policy Consensus Group

Scandlen Testifies at Maryland Senate Hearing

POSTED BY Galen Institute on February 12, 2003.

 

Greg Scandlen, director of Galen’s new Center for Consumer Driven Health Care, testified before the Maryland Senate Finance Committee on Health Reimbursement Arrangements on February 12.

He was speaking about a bill (SB 609) introduced by Senate minority whip Andrew Harris (R) that would require Maryland’s Health Care Access Commission to allow small employers to set up HRAs. In Maryland the benefit design of all small employer health insurance plans must be approved by the Commission before they can be made available to employers.

Mr. Scandlen explained the Internal Revenue Notice and Ruling on HRAs, and illustrated how they are being implemented in the marketplace. He explained that, “we are currently in a period of experimentation to see what the best plan design is.”

He pointed out that all employers, but especially small employers, are hard-pressed to maintain coverage these days. “With health plan premiums rising on average 15 to 17 percent this year — and in the small group market often by 30 to 40 percent – employers everywhere are raising deductibles, co-payments, coinsurance, and employee premiums. HRAs enable employers to soften the blow of these increases and at the same time increase the flexibility and worker satisfaction with their health plans.”

SB 609 is only one of several bills in the Maryland legislature aimed at enabling the use of HRAs. Mr. Scandlen offered to work with the Finance Committee to better understand the impact of all these proposals.

Click here to read Mr. Scandlen’s testimony.

Filed Under: Uncategorized

Scandlen Testifies at Maryland Senate Hearing

POSTED BY Galen Institute on February 12, 2003.

 

Greg Scandlen, director of Galen’s new Center for Consumer Driven Health Care, testified before the Maryland Senate Finance Committee on Health Reimbursement Arrangements on February 12.

He was speaking about a bill (SB 609) introduced by Senate minority whip Andrew Harris (R) that would require Maryland’s Health Care Access Commission to allow small employers to set up HRAs. In Maryland the benefit design of all small employer health insurance plans must be approved by the Commission before they can be made available to employers.

Mr. Scandlen explained the Internal Revenue Notice and Ruling on HRAs, and illustrated how they are being implemented in the marketplace. He explained that, “we are currently in a period of experimentation to see what the best plan design is.”

He pointed out that all employers, but especially small employers, are hard-pressed to maintain coverage these days. “With health plan premiums rising on average 15 to 17 percent this year — and in the small group market often by 30 to 40 percent – employers everywhere are raising deductibles, co-payments, coinsurance, and employee premiums. HRAs enable employers to soften the blow of these increases and at the same time increase the flexibility and worker satisfaction with their health plans.”

SB 609 is only one of several bills in the Maryland legislature aimed at enabling the use of HRAs. Mr. Scandlen offered to work with the Finance Committee to better understand the impact of all these proposals.

Click here to read Mr. Scandlen’s testimony.

Filed Under: Uncategorized

Primary Sidebar

Our Annual Report

Health Care Choices 20/20:

A Vision for the Future

SEARCH

Categories

  • Brian Blase
  • Consumer-Directed Care
  • Doug Badger
  • Grace-Marie Turner
  • Health Insurance
  • Health Policy Consensus Group
  • Health Savings Accounts
  • Innovation
  • Medicaid
  • Medicare
  • Newsletter
  • ObamaCare
  • Prescription Drugs
  • Published
    • Forbes
    • Fox Business
    • Health Affairs
    • LA Times
    • National Review
    • New York Post
    • RealClearHealth
    • Sun Sentinel
    • The Daily Signal
    • The Heritage Foundation
    • The Hill
    • The New York Times
    • The Wall Street Journal
    • The Washington Times
  • Reform Initiatives
  • State Issues
  • Uncategorized

LATEST NEWSLETTER ISSUES

SUBSCRIBE

Social Media

Like Us On Facebook

Twitter: @galeninstitute

 

Copyright Galen Institute at Donors. © 2023; · Log in